Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.

@article{Villar2020DexamethasoneTF,
  title={Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.},
  author={J. Villar and C. Ferrando and Domingo Mart{\'i}nez and A. Ambr{\'o}s and T. Mu{\~n}oz and J. Soler and G. Aguilar and F. Alba and E. Gonz{\'a}lez-Higueras and Lu{\'i}s A Conesa and C. Mart{\'i}n-Rodr{\'i}guez and F. D{\'i}az-Dom{\'i}nguez and Pablo Serna-Grande and R. Rivas and J. Ferreres and J. Belda and L. Capilla and Alec Tallet and J. M. A{\~n}{\'o}n and R. L. Fern{\'a}ndez and J. Gonz{\'a}lez-Mart{\'i}n},
  journal={The Lancet. Respiratory medicine},
  year={2020}
}
BACKGROUND There is no proven specific pharmacological treatment for patients with the acute respiratory distress syndrome (ARDS). The efficacy of corticosteroids in ARDS remains controversial. We aimed to assess the effects of dexamethasone in ARDS, which might change pulmonary and systemic inflammation and result in a decrease in duration of mechanical ventilation and mortality. METHODS We did a multicentre, randomised controlled trial in a network of 17 intensive care units (ICUs) in… Expand
247 Citations

Paper Mentions

Interventional Clinical Trial
Background: There are no proven therapies specific for pulmonary dysfunction in patients with acute hypoxemic respiratory failure (AHRF) caused by infections (including Covid-19). The… Expand
ConditionsAcute Hypoxemic Respiratory Failure
InterventionDrug
Interventional Clinical Trial
Prospective, multi-centre, randomized (1:1), parallel group, open-label, study comparing superiority of dexamethasone 20 mg vs. 6 mg. This is an open label study, in which all the… Expand
ConditionsARDS, Covid19
InterventionDrug
Interventional Clinical Trial
Background: There are no proven therapies specific for Covid-19. The full spectrum of Covid-19 ranges from asymptomatic disease to mild respiratory tract illness to severe… Expand
ConditionsAcute Respiratory Distress Syndrome Caused by COVID-19
InterventionDrug
Use of glucocorticoids in patients with acute respiratory distress syndrome: a meta-analysis and trial sequential analysis
  • 6
Corticosteroids for patients with acute respiratory distress syndrome: a systematic review and meta-analysis of randomized trials.
  • 12
  • Highly Influenced
COVID-19 and Acute Respiratory Distress Syndrome. Impact of corticosteroid treatment and predictors of poor outcome
  • 1
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 51 REFERENCES
Prone positioning in severe acute respiratory distress syndrome.
  • 1,506
  • PDF
Dexamethasone in patients with acute lung injury from acute monocytic leukaemia
  • 58
  • PDF
...
1
2
3
4
5
...